Cytokines and fibrinolytic enzymes in tuberculous and parapneumonic effusions

Tuberculous (TB) pleurisy and parapneumonic effusion (PPE) are common causes of pleural fibrosis. The mechanisms underlying fibrin deposition may be different since involved inflammatory cells are distinct. In this study, we measured various cytokines and fibrinolytic enzymes and compared the differ...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 116(2005), 2 vom: 01. Aug., Seite 166-73
1. Verfasser: Lin, Fang-Chi (VerfasserIn)
Weitere Verfasser: Chen, Yi-Chu, Chen, Funn-Juh, Chang, Shi-Chuan
Format: Aufsatz
Sprache:English
Veröffentlicht: 2005
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Comparative Study Journal Article Research Support, Non-U.S. Gov't CCL2 protein, human Chemokine CCL2 Chemokine CCL4 Cytokines Interleukins Macrophage Inflammatory Proteins Plasminogen Activator Inhibitor 1 mehr... Tumor Necrosis Factor-alpha Tissue Plasminogen Activator EC 3.4.21.68
LEADER 01000naa a22002652 4500
001 NLM155406108
003 DE-627
005 20231223072049.0
007 tu
008 231223s2005 xx ||||| 00| ||eng c
028 5 2 |a pubmed24n0518.xml 
035 |a (DE-627)NLM155406108 
035 |a (NLM)15897010 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Lin, Fang-Chi  |e verfasserin  |4 aut 
245 1 0 |a Cytokines and fibrinolytic enzymes in tuberculous and parapneumonic effusions 
264 1 |c 2005 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 12.09.2005 
500 |a Date Revised 15.11.2007 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a Tuberculous (TB) pleurisy and parapneumonic effusion (PPE) are common causes of pleural fibrosis. The mechanisms underlying fibrin deposition may be different since involved inflammatory cells are distinct. In this study, we measured various cytokines and fibrinolytic enzymes and compared the differences between the two effusions. PPE was further divided into noncomplicated PPE and complicated PPE/empyema subgroups. Tumor necrosis factor (TNF)-alpha, interleukin (IL)-1beta, IL-6, IL-8, macrophage inflammatory protein (MIP)-1beta, monocyte chemoattractant protein (MCP)-1, plasminogen activator inhibitor type 1 (PAI-1) and tissue type plasminogen activator (tPA) were measured using enzyme-linked immunosorbent assays. Significantly higher values of PAI-1, PAI-1/tPA ratio, IL-1beta, IL-8 and MIP-1beta and significantly lower values of TNF-alpha, IL-6 and MCP-1 were observed in PPE/empyema than in TB effusions. Compared to noncomplicated PPE, complicated PPE/empyema had significantly higher levels of TNF-alpha, IL-1beta, IL-8 and MIP-1beta. TB pleurisy patients who had higher effusion levels of TNF-alpha, IL-1beta and IL-8 were predisposing to residual pleural thickening. The underlying mechanisms of fibrin formation and deposition between the two effusions studied (PPE/empyema and TB pleurisy) could not be fully explained by the results of the present study. More studies are needed to explore this further 
650 4 |a Comparative Study 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 7 |a CCL2 protein, human  |2 NLM 
650 7 |a Chemokine CCL2  |2 NLM 
650 7 |a Chemokine CCL4  |2 NLM 
650 7 |a Cytokines  |2 NLM 
650 7 |a Interleukins  |2 NLM 
650 7 |a Macrophage Inflammatory Proteins  |2 NLM 
650 7 |a Plasminogen Activator Inhibitor 1  |2 NLM 
650 7 |a Tumor Necrosis Factor-alpha  |2 NLM 
650 7 |a Tissue Plasminogen Activator  |2 NLM 
650 7 |a EC 3.4.21.68  |2 NLM 
700 1 |a Chen, Yi-Chu  |e verfasserin  |4 aut 
700 1 |a Chen, Funn-Juh  |e verfasserin  |4 aut 
700 1 |a Chang, Shi-Chuan  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Clinical immunology (Orlando, Fla.)  |d 1999  |g 116(2005), 2 vom: 01. Aug., Seite 166-73  |w (DE-627)NLM098196855  |x 1521-7035  |7 nnns 
773 1 8 |g volume:116  |g year:2005  |g number:2  |g day:01  |g month:08  |g pages:166-73 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 116  |j 2005  |e 2  |b 01  |c 08  |h 166-73